Table 3 Outcome analysis comparing β-lactam versus vancomycin group. Variables were adjusted for predefined confounding variables, including age, sex, age-adjusted Charlson-comorbidity index, Pitt bacteremia score, infectious diseases consultation, infective endocarditis and time to receipt of empiric antibiotics. Duration of bacteremia was further adjusted for surgical source control

Outcomes

Crude OR (95 % CI)

P-value

Adjusted OR (95 % CI)

P-value

28-day mortality

0.88 (0.44–1.78)

0.72

1.14 (0.49–2.64)

0.76

90-day mortality

0.75 (0.43–1.32)

0.32

1.01 (0.51–2.02)

0.97

Recurrent infection at 6 months

0.87 (0.31–2.45)

0.79

1.27 (0.39–4.11)

0.69

Ratio of Mean (95 % CI)

P-value

Adjusted Ratio of Mean (95 % CI)

P-value

Duration of bacteremia

0.92 (0.78–1.07)

0.27

0.94 (0.79–1.11)

0.44

Hospital length-of-stay

0.96 (0.81–1.14)

0.65

0.95 (0.80–1.14)

0.60